Trulieve Cannabis Corp. TRLV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -20.12% | -10.31% | -3.70% | -2.67% | 1.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.12% | -10.31% | -3.70% | -2.67% | 1.37% |
| Cost of Revenue | -30.54% | -8.81% | 1.86% | 3.39% | 6.60% |
| Gross Profit | -12.86% | -11.28% | -7.17% | -6.37% | -1.97% |
| SG&A Expenses | -11.28% | 0.64% | -11.68% | -20.03% | -33.38% |
| Depreciation & Amortization | -39.89% | -12.59% | 1.42% | 2.64% | 3.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.93% | -5.43% | -4.31% | -8.98% | -14.29% |
| Operating Income | 2.62% | -33.57% | 0.92% | 4,319.13% | 1,225.12% |
| Income Before Tax | -7.77% | -1,085.49% | 24.07% | 122.48% | 328.25% |
| Income Tax Expenses | -50.50% | -59.86% | -58.34% | 0.69% | 11.93% |
| Earnings from Continuing Operations | 103.26% | -2,462.99% | 110.46% | 25.59% | 60.59% |
| Earnings from Discontinued Operations | -- | -136.95% | 33.54% | 228.56% | -208.62% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -95.13% | -96.27% | -86.16% | -60.61% | 18.62% |
| Net Income | 103.24% | -2,846.12% | 107.32% | 28.24% | 55.43% |
| EBIT | 2.62% | -33.57% | 0.92% | 4,319.13% | 1,225.12% |
| EBITDA | -14.58% | -22.59% | 1.11% | 48.07% | 123.36% |
| EPS Basic | 103.21% | -2,821.78% | 107.27% | 16.24% | 57.15% |
| Normalized Basic EPS | -14.65% | -992.78% | 5.97% | 189.14% | 316.14% |
| EPS Diluted | 103.06% | -2,821.78% | 107.27% | 16.24% | 57.15% |
| Normalized Diluted EPS | -17.94% | -992.78% | 5.97% | 189.14% | 316.14% |
| Average Basic Shares Outstanding | 0.87% | 0.79% | 0.74% | 0.89% | 0.57% |
| Average Diluted Shares Outstanding | 4.88% | 0.79% | 0.74% | 0.89% | 0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |